Moderna and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna’s mRNA respiratory vaccine portfolio in Japan, including Moderna’s COVID-19 vaccine. Learn more: https://lnkd.in/eNE5P_Tj.
Exciting collaboration! This partnership between Moderna and Mitsubishi Tanabe Pharma is a significant step towards expanding access to mRNA respiratory vaccines in Japan, including for COVID-19. #COVID19 #Vaccines
Who was the first to show mRNA could be used as vaccine, ehh ?
Good ol' Moderna... always trying to 'help' people...
🤥🤥🤥
Well done! Congratulations
#cambridgepoison
Congratulations to you, Kazu and Moderna Japan!
Keep us updated Francesca!
GxP Quality Assurance Manager | I help Life Science Companies with CMO, External Manufacturing Quality oversight, Batch Release, Validation, Audits, GAP assessments, Training | NPI projects | Annex 1 🚀
1moCongratulations, Moderna This is a significant milestone in your commitment to enhancing patient health. Keep up the great work.